Efgartigimod alfa-fcab Injection

Efgartigimod alfa-fcab injection is used to treat a certain form of myasthenia gravis (MG; a disorder of the nervous system that causes muscle weakness). Efgartigimod alfa-fcab is in a group of medications called monoclonal antibodies. It works by reducing a certain natural substance in the body that causes symptoms of myasthenia gravis.

🔔 How should this medicine be used?

Efgartigimod alfa-fcab comes as a solution (liquid) to be injected slowly into a vein over 60 minutes by a healthcare provider. It is usually given once a week for 4 weeks. The cycle may be repeated as recommended by your doctor, but no sooner than at least 50 days after your last weekly dose. The length of your treatment depends on how well your body responds to the medication and any side effects that you experience.

Efgartigimod alfa-fcab injection may cause serious allergic reactions. Your healthcare provider will watch you carefully while you are receiving efgartigimod alfa-fcab injection and for 1 hour after you receive the medication. Your doctor may slow or stop your infusion if you have an allergic reaction. If you experience any of the following symptoms, tell your doctor immediately: chest pain; feeling faint; rash; hives; swelling of the eyes, face, lips, tongue, or throat; hoarseness; or difficulty breathing or swallowing.

Ask your pharmacist or doctor for a copy of the manufacturer’s information for the patient.